tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP

Adaptimmune Therapeutics (ADAP) Technical Analysis

690 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 1.16, while Adaptimmune Therapeutics’s (ADAP) share price is $1.14, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 1.21, while Adaptimmune Therapeutics’s (ADAP) share price is $1.14, making it a Sell.

Adaptimmune Therapeutics (ADAP) Pivot Points

May 10, 2024, 05:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.94
0.98
1.06
1.10
1.18
1.22
1.30
Fibonacci
0.98
1.03
1.05
1.10
1.15
1.17
1.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAP) Moving Averages

May 10, 2024, 05:44 AM
Period
Simple
Exponential
MA5
1.14Sell
1.14Sell
MA10
1.15Sell
1.14Sell
MA20
1.10Buy
1.16Sell
MA50
1.32Sell
1.21Sell
MA100
1.13Buy
1.14Buy
MA200
0.91Buy
1.02Buy
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 1.14, while Adaptimmune Therapeutics’s (ADAP) share price is $1.14, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 1.14, while Adaptimmune Therapeutics’s (ADAP) share price is $1.14, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.14 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 1.32, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.14 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 1.13, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $1.14 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.91, creating a Buy signal.

Adaptimmune Therapeutics (ADAP) Technical Indicators

May 10, 2024, 05:44 AM
Name
Value
Implied Action
RSI (14)
46.40
Neutral
STOCH (9,6)
45.39
Neutral
STOCHRSI (14)
63.83
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
14.69
Buy
Williams %R
-35.48
Buy
CCI (14)
60.47
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
47.09
Neutral
ROC
16.33
Buy
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 46.40, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 14.69, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is 60.47, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is 16.33, creating a Buy signal.

FAQ

Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Hold.
    What is ADAP’s RSI (14)?
    ADAP’s RSI (14) is 46.40, which suggests ADAP is a Neutral.
      What is ADAP’s MACD?
      ADAP’s MACD is -0.04, which suggests ADAP is a Sell.
        What is ADAP’s 5-day moving average?
        ADAP’s 5-day moving average is 1.14, which suggests ADAP is a Sell.
          What is ADAP’s 20-day moving average?
          ADAP 20-day moving average is 1.10, which suggests ADAP is a Buy.
            What is ADAP’s 50-day moving average?
            ADAP’s 50-day moving average is 1.32, which suggests ADAP is a Sell.
              What is ADAP’s 200-day moving average?
              ADAP’s 200-day moving average is 0.91, which suggests ADAP is a Buy.
                What is ADAP’s Williams % R (14)?
                ADAP’s Williams % R (14) is -35.48, which suggests ADAP is a Buy.
                  What is ADAP’s CCI (14)?
                  ADAP’s CCI (14) is 60.47, which suggests ADAP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis